# Jasper Therapeutics (JSPR) — Earnings

JSPR · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/jspr/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q3 2025 |
| Period end | Sep 30, 2025 |
| EPS actual | −$1.13 |
| EPS estimate | −$1.21 |
| EPS surprise | +6.99% |
| Revenue surprise | +0.00% |
| Revenue | $0.00 |
| Revenue estimate | $0.00 |
| Reported | Nov 10, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1788028/000121390025107884/ea0263643-10q_jasper.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q3 2025 | Nov 10, 2025 | −$1.21 | −$1.13 | 6.99% | — | — |
| Q2 2025 | Aug 13, 2025 | −$1.33 | −$1.74 | -31.19% | — | — |
| Q1 2025 | May 12, 2025 | −$1.35 | −$1.41 | -4.63% | — | — |
| Q4 2024 | Feb 27, 2025 | −$1.25 | −$1.62 | -29.17% | — | — |
| Q3 2024 | Nov 7, 2024 | −$1.07 | −$1.24 | -15.75% | — | — |
| Q2 2024 | Aug 13, 2024 | −$1.09 | −$0.97 | 10.89% | — | — |
| Q1 2024 | May 14, 2024 | −$1.23 | −$1.03 | 15.92% | — | — |
| Q4 2023 | Mar 4, 2024 | −$1.61 | −$1.50 | 6.76% | — | — |
| Q3 2023 | Nov 9, 2023 | −$1.55 | −$1.60 | -3.09% | — | — |
| Q2 2023 | Aug 11, 2023 | −$1.48 | −$1.50 | -1.03% | — | — |
| Q1 2023 | May 12, 2023 | −$1.62 | −$1.60 | 1.42% | — | — |
| Q4 2022 | Mar 8, 2023 | −$3.74 | −$3.60 | 3.75% | — | — |
| Q3 2022 | Nov 10, 2022 | −$3.40 | −$3.04 | 10.71% | — | — |
| Q2 2022 | Aug 12, 2022 | −$3.13 | −$2.90 | 7.45% | — | — |
| Q1 2022 | May 12, 2022 | −$3.50 | −$0.60 | 82.86% | — | — |
| Q4 2021 | Mar 18, 2022 | −$3.44 | −$2.40 | 30.16% | — | — |
| Q3 2021 | Nov 12, 2021 | −$3.09 | −$6.90 | -123.64% | — | — |

## Frequently Asked Questions

### When did Jasper Therapeutics (JSPR) last report earnings?

Jasper Therapeutics last reported on Nov 10, 2025, covering fiscal Q3 2025.

### Did JSPR beat earnings estimates?

Yes. Jasper Therapeutics reported EPS of −$1.13 for Q3 2025 against a −$1.21 estimate — a 6.99% beat.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).